Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jul 19;113(29):7944-5.
doi: 10.1073/pnas.1608860113. Epub 2016 Jul 7.

Harnessing shared antigens and T-cell receptors in cancer: Opportunities and challenges

Kavita Dhodapkar  1 , Madhav Dhodapkar  2
Affiliations
Comment

Harnessing shared antigens and T-cell receptors in cancer: Opportunities and challenges

Kavita Dhodapkar et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

  • Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR.
    Munson DJ, Egelston CA, Chiotti KE, Parra ZE, Bruno TC, Moore BL, Nakano TA, Simons DL, Jimenez G, Yim JH, Rozanov DV, Falta MT, Fontenot AP, Reynolds PR, Leach SM, Borges VF, Kappler JW, Spellman PT, Lee PP, Slansky JE. Munson DJ, et al. Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8272-7. doi: 10.1073/pnas.1606994113. Epub 2016 Jun 15. Proc Natl Acad Sci U S A. 2016. PMID: 27307436 Free PMC article.

References

    1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264. - PMC - PubMed
    1. Gubin MM, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature. 2014;515(7528):577–581. - PMC - PubMed
    1. Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348(6230):69–74. - PubMed
    1. Alexandrov LB, et al. Australian Pancreatic Cancer Genome Initiative; ICGC Breast Cancer Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–421. - PMC - PubMed
    1. Bindea G, Mlecnik B, Angell HK, Galon J. The immune landscape of human tumors: Implications for cancer immunotherapy. OncoImmunology. 2014;3(1):e27456. - PMC - PubMed